These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 35865948)
21. Effectiveness of a Glycylcycline Antibiotic for Reducing the Pathogenicity of Superantigen-Producing Methicillin-Resistant Nosanov LB; Jo DY; Randad PR; Moffatt LT; Carney BC; Ortiz RT; Shupp JW Eplasty; 2017; 17():e27. PubMed ID: 28943993 [No Abstract] [Full Text] [Related]
22. A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline. McAleese F; Petersen P; Ruzin A; Dunman PM; Murphy E; Projan SJ; Bradford PA Antimicrob Agents Chemother; 2005 May; 49(5):1865-71. PubMed ID: 15855508 [TBL] [Abstract][Full Text] [Related]
23. Spontaneous Knee Hemarthrosis Due to Hypofibrinogenemia Following Tigecycline Treatment for Periprosthetic Joint Infection. Balfousias T; Apostolopoulos AP; Angelis S; Maris S; Papanikolaou A Cureus; 2019 Oct; 11(10):e5883. PubMed ID: 31772853 [TBL] [Abstract][Full Text] [Related]
24. In vitro activity of tigecycline against quinolone-resistant Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. Garrison MW; Nuemiller JJ Int J Antimicrob Agents; 2007 Feb; 29(2):191-6. PubMed ID: 17174074 [TBL] [Abstract][Full Text] [Related]
25. Tigecycline in the Treatment of Patients with Necrotizing Skin and Soft Tissue Infections Due to Multiresistant Bacteria. Eckmann C; Heizmann W; Bodmann KF; von Eiff C; Petrik C; Loeschmann PA Surg Infect (Larchmt); 2015 Oct; 16(5):618-25. PubMed ID: 26115414 [TBL] [Abstract][Full Text] [Related]
26. Sub-Inhibitory Concentrations of Oxacillin, but Not Clindamycin, Linezolid, or Tigecycline, Decrease Staphylococcal Phenol-Soluble Modulin Expression in Community-Acquired Methicillin-Resistant Staphylococcus aureus. Hodille E; Beraud L; Périan S; Berti V; Bes M; Tristan A; Blond E; Lina G; Dumitrescu O Microbiol Spectr; 2022 Feb; 10(1):e0080821. PubMed ID: 35044221 [TBL] [Abstract][Full Text] [Related]
27. Tigecycline and inducible clindamycin resistance in clinical isolates of methicillin-resistant Che Hamzah AM; Yeo CC; Puah SM; Chua KH; A Rahman NI; Abdullah FH; Othman N; Chew CH J Med Microbiol; 2019 Sep; 68(9):1299-1305. PubMed ID: 31140965 [TBL] [Abstract][Full Text] [Related]
28. Effect of natural honey on human platelets and blood coagulation proteins. Ahmed A; Khan RA; Azim MK; Saeed SA; Mesaik MA; Ahmed S; Imran I Pak J Pharm Sci; 2011 Jul; 24(3):389-97. PubMed ID: 21715274 [TBL] [Abstract][Full Text] [Related]
29. Tigecycline-induced coagulopathy: a literature review. Cui N; Cai H; Li Z; Lu Y; Wang G; Lu A Int J Clin Pharm; 2019 Dec; 41(6):1408-1413. PubMed ID: 31713108 [TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo activities of tigecycline (GAR-936), daptomycin, and comparative antimicrobial agents against glycopeptide-intermediate Staphylococcus aureus and other resistant gram-positive pathogens. Petersen PJ; Bradford PA; Weiss WJ; Murphy TM; Sum PE; Projan SJ Antimicrob Agents Chemother; 2002 Aug; 46(8):2595-601. PubMed ID: 12121938 [TBL] [Abstract][Full Text] [Related]
32. Effects of extracts and isolated compounds from safflower on some index of promoting blood circulation and regulating menstruation. Yao D; Wang Z; Miao L; Wang L J Ethnopharmacol; 2016 Sep; 191():264-272. PubMed ID: 27286914 [TBL] [Abstract][Full Text] [Related]
33. [Filtration of active fractions with hemostasis effect from platycladi cacumen carbonisatum]. Liu C; Liu J; Zheng CZ; Zhang L; Ding AW; Yu B Zhongguo Zhong Yao Za Zhi; 2014 Aug; 39(16):3152-6. PubMed ID: 25509305 [TBL] [Abstract][Full Text] [Related]
34. Tigecycline-associated hypofibrinogenemia in a real-world setting. Campany-Herrero D; Larrosa-Garcia M; Lalueza-Broto P; Rivera-Sánchez L; Espinosa-Pereiro J; Mestre-Torres J; Pigrau-Serrallach C Int J Clin Pharm; 2020 Aug; 42(4):1184-1189. PubMed ID: 32504166 [TBL] [Abstract][Full Text] [Related]
35. Influence of tigecycline on expression of virulence factors in biofilm-associated cells of methicillin-resistant Staphylococcus aureus. Smith K; Gould KA; Ramage G; Gemmell CG; Hinds J; Lang S Antimicrob Agents Chemother; 2010 Jan; 54(1):380-7. PubMed ID: 19858261 [TBL] [Abstract][Full Text] [Related]
36. Daptomycin and tigecycline have broader effective dose ranges than vancomycin as prophylaxis against a Staphylococcus aureus surgical implant infection in mice. Niska JA; Shahbazian JH; Ramos RI; Pribaz JR; Billi F; Francis KP; Miller LS Antimicrob Agents Chemother; 2012 May; 56(5):2590-7. PubMed ID: 22371896 [TBL] [Abstract][Full Text] [Related]
37. The Role of Subinhibitory Concentrations of Daptomycin and Tigecycline in Modulating Virulence in Atshan SS; Hamat RA; Coolen MJL; Dykes G; Sekawi Z; Mullins BJ; Than LTL; Abduljaleel SA; Kicic A Antibiotics (Basel); 2021 Jan; 10(1):. PubMed ID: 33401579 [No Abstract] [Full Text] [Related]
38. In vitro activity of tigecycline against patient isolates collected during phase 3 clinical trials for hospital acquired pneumonia. Petersen PJ; Tuckman M; Jones CH Infect Dis Rep; 2010 Feb; 2(1):e1. PubMed ID: 24470884 [TBL] [Abstract][Full Text] [Related]
39. Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease. Cai Y; Wang R; Liang B; Bai N; Liu Y Antimicrob Agents Chemother; 2011 Mar; 55(3):1162-72. PubMed ID: 21173186 [TBL] [Abstract][Full Text] [Related]
40. Tigecycline-associated hypofibrinogenemia: A case report and review of the literature. Wu PC; Wu CC IDCases; 2018; 11():56-57. PubMed ID: 29560313 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]